logo
welcome
Live Science

Live Science

CRISPR could be used to treat UTIs, early trial hints

Live Science
Summary
Nutrition label

80% Informative

The treatment harnesses bacteriophages, or viruses that infect bacteria.

Phages are being developed as a potential alternative to conventional antibiotics.

LBP-EC01 is designed to kill Escherichia coli, the main culprit behind UTIs.

The treatment is being tested for uncomplicated UTIs, meaning those that don't involve structural abnormalities.

Send us your questions about how the human body works to [email protected] with the subject line "Health Desk Q ," and you may see your question answered on the website! Nicoletta Lanese is the health channel editor at Live Science .

She holds a graduate certificate in science communication from UC Santa Cruz and degrees in neuroscience and dance from the University of Florida .